News Details

( As on 22/04/2026 12:27)

GlaxoSmith. Pharma. - Board Meeting Intimation for Audited Financial Results (Standalone & Consolidated) For The Year Ended 3

Glaxosmithkline Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/05/2026 ,inter alia, to consider and approve Audited Financial Results (Standalone & Consolidated) for the year ended 31st March 2026 and dividend if any